Source:http://linkedlifedata.com/resource/pubmed/id/12648234
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-3-21
|
pubmed:abstractText |
Squamous cell carcinomas in psoralen-plus-ultraviolet A (PUVA) treated patients frequently exhibit p53 tumor suppressor genes and Ha-ras protooncogenes that are mutated at dipyrimidine sites and carry the ultraviolet fingerprint (i.e., C-to-T or CC-to-TT transitions). To further broaden the knowledge of genetic mutations in PUVA-associated skin cancer, we used DNA sequencing analysis to study the mutational spectrum of the INK4a-ARF locus in 26 squamous cell carcinomas from 11 long-term PUVA-treated psoriasis patients and classified the mutations by origin (ultraviolet, ultraviolet and/or PUVA, or other). Nineteen INK4a-ARF missense/nonsense mutations were found in exons 1alpha, 1beta, and 2 in 11 of 26 squamous cell carcinomas (42%) from seven of 11 patients (64%). Eleven mutations (58%) were of the ultraviolet type; three (16%) were of the ultraviolet and/or PUVA type (i.e., C-to-T transitions at dipyrimidine sites opposite a 5'TpG sequence, a potential psoralen binding site); and five (26%) were of other type. Interestingly, 10 of 11 patients (91%) showed intron polymorphism C500G at the 3' untranslated region of exon 3. These data indicate that (i) INK4a-ARF mutations frequently occur in PUVA-associated squamous cell carcinomas; (ii) ultraviolet B radiation is the major cause of these mutations; and (iii) PUVA itself may play no direct role in development of most INK4a-ARF mutations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Ficusin,
http://linkedlifedata.com/resource/pubmed/chemical/Photosensitizing Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p14ARF
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-202X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
120
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
676-82
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12648234-Adult,
pubmed-meshheading:12648234-Carcinoma, Squamous Cell,
pubmed-meshheading:12648234-Cyclin-Dependent Kinase Inhibitor p16,
pubmed-meshheading:12648234-DNA Fingerprinting,
pubmed-meshheading:12648234-DNA Mutational Analysis,
pubmed-meshheading:12648234-Female,
pubmed-meshheading:12648234-Ficusin,
pubmed-meshheading:12648234-Humans,
pubmed-meshheading:12648234-Male,
pubmed-meshheading:12648234-Middle Aged,
pubmed-meshheading:12648234-Mutation,
pubmed-meshheading:12648234-PUVA Therapy,
pubmed-meshheading:12648234-Photosensitizing Agents,
pubmed-meshheading:12648234-Polymorphism, Single-Stranded Conformational,
pubmed-meshheading:12648234-Psoriasis,
pubmed-meshheading:12648234-Skin Neoplasms,
pubmed-meshheading:12648234-Tumor Suppressor Protein p14ARF
|
pubmed:year |
2003
|
pubmed:articleTitle |
High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
|
pubmed:affiliation |
Department of Dermatology, Karl-Franzens University, Graz, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|